Cargando…

Pharmacological Effects of Methotrexate and Infliximab in a Rats Model of Diet-Induced Dyslipidemia and Beta-3 Overexpression on Endothelial Cells

Background: Hyperlipidemia and inflammation are critical components in the pathophysiology of endothelial disorder, which can lead to vascular complications. Our study aimed to evaluate the effects of immunomodulatory therapy (methotrexate and infliximab) in a diet-induced hyperlipidemia rat model....

Descripción completa

Detalles Bibliográficos
Autores principales: Zălar, Denisa-Mădălina, Pop, Cristina, Buzdugan, Elena, Kiss, Bela, Ştefan, Maria-Georgia, Ghibu, Steliana, Bâlteanu, Valentin-Adrian, Crişan, Doiniţa, Buruiană-Simic, Alexandra, Grozav, Adriana, Mogoșan, Cristina Ionela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306833/
https://www.ncbi.nlm.nih.gov/pubmed/34300308
http://dx.doi.org/10.3390/jcm10143143
_version_ 1783727905783676928
author Zălar, Denisa-Mădălina
Pop, Cristina
Buzdugan, Elena
Kiss, Bela
Ştefan, Maria-Georgia
Ghibu, Steliana
Bâlteanu, Valentin-Adrian
Crişan, Doiniţa
Buruiană-Simic, Alexandra
Grozav, Adriana
Mogoșan, Cristina Ionela
author_facet Zălar, Denisa-Mădălina
Pop, Cristina
Buzdugan, Elena
Kiss, Bela
Ştefan, Maria-Georgia
Ghibu, Steliana
Bâlteanu, Valentin-Adrian
Crişan, Doiniţa
Buruiană-Simic, Alexandra
Grozav, Adriana
Mogoșan, Cristina Ionela
author_sort Zălar, Denisa-Mădălina
collection PubMed
description Background: Hyperlipidemia and inflammation are critical components in the pathophysiology of endothelial disorder, which can lead to vascular complications. Our study aimed to evaluate the effects of immunomodulatory therapy (methotrexate and infliximab) in a diet-induced hyperlipidemia rat model. Methods: Sprague-Dawley (wild type (WT), male, n = 32) rats were divided into four groups: one group fed with standard diet (SD), one group fed with high lipid diet (HLD), and two groups that received HLD and drug treatment (methotrexate (Mtx) or infliximab (Ifx)). In order to evaluate if modifications to the endothelial cells may influence the risk of vascular complications following hyperlipidemia or treatment reactivity, each group was doubled by a rats group that overexpressed beta-3 receptors on the endothelial cells (transgenic (TG-beta 3), male, n = 32). Serum lipid profile, liver enzymes, oxidative stress, and inflammation markers were determined. Histopathologic analysis of the liver and aorta was performed. Results: After 9 weeks of HLD, rats exhibited significant pathologic serum lipid profiles, elevated oxidative stress, and pro-inflammatory markers. Additionally, the aortic histopathological analysis revealed aorta media-intima thickening (p < 0.05) in the transgenic group. Methotrexate and infliximab significantly decreased inflammation and oxidative stress parameters, but presented opposing effects on lipid profiles (methotrexate decreased, whereas infliximab increased the atherosclerosis index). Drug treatment decreased the aorta media-intima thickness (p < 0.05) only in transgenic rats. Conclusions: HLD was associated with hyperlipidemia, inflammation and oxidative stress. The overexpression of beta-3 receptors on endothelial cells increased aortic thickening in response to the HLD. Methotrexate and infliximab reduced oxidative stress and inflammation in all groups, but led to favorable histopathologic vascular results only in the transgenic groups.
format Online
Article
Text
id pubmed-8306833
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83068332021-07-25 Pharmacological Effects of Methotrexate and Infliximab in a Rats Model of Diet-Induced Dyslipidemia and Beta-3 Overexpression on Endothelial Cells Zălar, Denisa-Mădălina Pop, Cristina Buzdugan, Elena Kiss, Bela Ştefan, Maria-Georgia Ghibu, Steliana Bâlteanu, Valentin-Adrian Crişan, Doiniţa Buruiană-Simic, Alexandra Grozav, Adriana Mogoșan, Cristina Ionela J Clin Med Article Background: Hyperlipidemia and inflammation are critical components in the pathophysiology of endothelial disorder, which can lead to vascular complications. Our study aimed to evaluate the effects of immunomodulatory therapy (methotrexate and infliximab) in a diet-induced hyperlipidemia rat model. Methods: Sprague-Dawley (wild type (WT), male, n = 32) rats were divided into four groups: one group fed with standard diet (SD), one group fed with high lipid diet (HLD), and two groups that received HLD and drug treatment (methotrexate (Mtx) or infliximab (Ifx)). In order to evaluate if modifications to the endothelial cells may influence the risk of vascular complications following hyperlipidemia or treatment reactivity, each group was doubled by a rats group that overexpressed beta-3 receptors on the endothelial cells (transgenic (TG-beta 3), male, n = 32). Serum lipid profile, liver enzymes, oxidative stress, and inflammation markers were determined. Histopathologic analysis of the liver and aorta was performed. Results: After 9 weeks of HLD, rats exhibited significant pathologic serum lipid profiles, elevated oxidative stress, and pro-inflammatory markers. Additionally, the aortic histopathological analysis revealed aorta media-intima thickening (p < 0.05) in the transgenic group. Methotrexate and infliximab significantly decreased inflammation and oxidative stress parameters, but presented opposing effects on lipid profiles (methotrexate decreased, whereas infliximab increased the atherosclerosis index). Drug treatment decreased the aorta media-intima thickness (p < 0.05) only in transgenic rats. Conclusions: HLD was associated with hyperlipidemia, inflammation and oxidative stress. The overexpression of beta-3 receptors on endothelial cells increased aortic thickening in response to the HLD. Methotrexate and infliximab reduced oxidative stress and inflammation in all groups, but led to favorable histopathologic vascular results only in the transgenic groups. MDPI 2021-07-16 /pmc/articles/PMC8306833/ /pubmed/34300308 http://dx.doi.org/10.3390/jcm10143143 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zălar, Denisa-Mădălina
Pop, Cristina
Buzdugan, Elena
Kiss, Bela
Ştefan, Maria-Georgia
Ghibu, Steliana
Bâlteanu, Valentin-Adrian
Crişan, Doiniţa
Buruiană-Simic, Alexandra
Grozav, Adriana
Mogoșan, Cristina Ionela
Pharmacological Effects of Methotrexate and Infliximab in a Rats Model of Diet-Induced Dyslipidemia and Beta-3 Overexpression on Endothelial Cells
title Pharmacological Effects of Methotrexate and Infliximab in a Rats Model of Diet-Induced Dyslipidemia and Beta-3 Overexpression on Endothelial Cells
title_full Pharmacological Effects of Methotrexate and Infliximab in a Rats Model of Diet-Induced Dyslipidemia and Beta-3 Overexpression on Endothelial Cells
title_fullStr Pharmacological Effects of Methotrexate and Infliximab in a Rats Model of Diet-Induced Dyslipidemia and Beta-3 Overexpression on Endothelial Cells
title_full_unstemmed Pharmacological Effects of Methotrexate and Infliximab in a Rats Model of Diet-Induced Dyslipidemia and Beta-3 Overexpression on Endothelial Cells
title_short Pharmacological Effects of Methotrexate and Infliximab in a Rats Model of Diet-Induced Dyslipidemia and Beta-3 Overexpression on Endothelial Cells
title_sort pharmacological effects of methotrexate and infliximab in a rats model of diet-induced dyslipidemia and beta-3 overexpression on endothelial cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306833/
https://www.ncbi.nlm.nih.gov/pubmed/34300308
http://dx.doi.org/10.3390/jcm10143143
work_keys_str_mv AT zalardenisamadalina pharmacologicaleffectsofmethotrexateandinfliximabinaratsmodelofdietinduceddyslipidemiaandbeta3overexpressiononendothelialcells
AT popcristina pharmacologicaleffectsofmethotrexateandinfliximabinaratsmodelofdietinduceddyslipidemiaandbeta3overexpressiononendothelialcells
AT buzduganelena pharmacologicaleffectsofmethotrexateandinfliximabinaratsmodelofdietinduceddyslipidemiaandbeta3overexpressiononendothelialcells
AT kissbela pharmacologicaleffectsofmethotrexateandinfliximabinaratsmodelofdietinduceddyslipidemiaandbeta3overexpressiononendothelialcells
AT stefanmariageorgia pharmacologicaleffectsofmethotrexateandinfliximabinaratsmodelofdietinduceddyslipidemiaandbeta3overexpressiononendothelialcells
AT ghibusteliana pharmacologicaleffectsofmethotrexateandinfliximabinaratsmodelofdietinduceddyslipidemiaandbeta3overexpressiononendothelialcells
AT balteanuvalentinadrian pharmacologicaleffectsofmethotrexateandinfliximabinaratsmodelofdietinduceddyslipidemiaandbeta3overexpressiononendothelialcells
AT crisandoinita pharmacologicaleffectsofmethotrexateandinfliximabinaratsmodelofdietinduceddyslipidemiaandbeta3overexpressiononendothelialcells
AT buruianasimicalexandra pharmacologicaleffectsofmethotrexateandinfliximabinaratsmodelofdietinduceddyslipidemiaandbeta3overexpressiononendothelialcells
AT grozavadriana pharmacologicaleffectsofmethotrexateandinfliximabinaratsmodelofdietinduceddyslipidemiaandbeta3overexpressiononendothelialcells
AT mogosancristinaionela pharmacologicaleffectsofmethotrexateandinfliximabinaratsmodelofdietinduceddyslipidemiaandbeta3overexpressiononendothelialcells